The antidoping labs, created by GlaxoSmithKline and supported by analysts from King’s College London for the Olympics, will become a biomarker centre for biomedical research. The MRC-NIHR Phenome Centre is reported to be the first of its kind in the world.

London 2012 unveils anti-doping laboratory with laboratory service providers GlaxoSmithKline (GSK) and laboratory operators King's College London

Source: London 2012

The phenome is the sum total of the physical characteristics and chemical markers in the body, and by looking at the patterns in the phenome, researchers will aim to find new biomarkers to predict disease risk and outcomes, helping doctors to create better-tailored treatments.